DE FRANCESCO, ERNESTINA MARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.847
AS - Asia 1.010
EU - Europa 674
SA - Sud America 341
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.907
Nazione #
US - Stati Uniti d'America 1.798
SG - Singapore 420
IE - Irlanda 398
BR - Brasile 273
HK - Hong Kong 253
CN - Cina 134
IT - Italia 90
VN - Vietnam 67
DE - Germania 47
GB - Regno Unito 33
BD - Bangladesh 31
AR - Argentina 25
FR - Francia 23
IN - India 22
CA - Canada 20
TR - Turchia 19
MX - Messico 18
FI - Finlandia 16
EC - Ecuador 11
IQ - Iraq 11
JP - Giappone 11
PL - Polonia 11
CO - Colombia 8
LT - Lituania 8
VE - Venezuela 8
ZA - Sudafrica 8
BE - Belgio 7
ID - Indonesia 7
EG - Egitto 6
ES - Italia 6
MA - Marocco 6
NL - Olanda 6
SE - Svezia 5
CL - Cile 4
JM - Giamaica 4
KR - Corea 4
NP - Nepal 4
PE - Perù 4
PK - Pakistan 4
PY - Paraguay 4
RU - Federazione Russa 4
CH - Svizzera 3
DZ - Algeria 3
MK - Macedonia 3
OM - Oman 3
SA - Arabia Saudita 3
UA - Ucraina 3
UY - Uruguay 3
UZ - Uzbekistan 3
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
NG - Nigeria 2
SN - Senegal 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MV - Maldive 1
MZ - Mozambico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 3.907
Città #
Dallas 685
Dublin 388
San Jose 295
Hong Kong 252
Singapore 200
Ashburn 126
Boardman 86
The Dalles 84
Chicago 83
Santa Clara 83
Beijing 65
Los Angeles 46
São Paulo 32
Ho Chi Minh City 23
Munich 22
Assago 16
Istanbul 14
Hanoi 12
Helsinki 12
Hillsboro 12
Belo Horizonte 11
Warsaw 11
New York 10
Rio de Janeiro 10
Frankfurt am Main 9
London 9
Tokyo 9
Atlanta 8
Council Bluffs 8
Brussels 7
Columbus 7
Lauterbourg 7
Milan 7
Orem 7
Guayaquil 6
Naples 6
Phoenix 6
Brooklyn 5
Cuiabá 5
Mexico City 5
Porto Alegre 5
Brasília 4
Chennai 4
Da Nang 4
Düsseldorf 4
Fortaleza 4
Johannesburg 4
Paris 4
Stockholm 4
São Bernardo do Campo 4
Toronto 4
Turku 4
Anoia Superiore 3
Campinas 3
Cape Town 3
Caracas 3
Casablanca 3
Caxias do Sul 3
Charlotte 3
Curitiba 3
Ezeiza 3
Florence 3
Haiphong 3
Kingston 3
Muscat 3
Ninh Bình 3
Ottawa 3
Pune 3
Salvador 3
San Francisco 3
Seoul 3
Skopje 3
Tashkent 3
Volta Redonda 3
Zurich 3
Amman 2
Amparo 2
Amsterdam 2
Asunción 2
Baghdad 2
Bari 2
Basra 2
Benevento 2
Bishkek 2
Biên Hòa 2
Boston 2
Camden 2
Canoas 2
Cardiff 2
Cetraro 2
Cincinnati 2
Dakar 2
Delhi 2
Denver 2
Dhaka 2
Edmonton 2
Favara 2
Fazenda Rio Grande 2
Florianópolis 2
Grammichele 2
Totale 2.857
Nome #
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 115
Cross-talk between GPER and growth factor signaling 93
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 85
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 77
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 75
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients 75
COVID-19 and Diabetes: The Importance of Controlling RAGE 73
Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine) 72
Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling 72
Environmental plastic pollutants and endocrine-related cancer: An updated view 71
Interleukin-1β mediates a tumor-supporting environment prompted by IGF1 in triple-negative breast cancer (TNBC) 71
A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER) 70
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: Mechanisms and models 69
Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts 68
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 68
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells 67
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 67
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience 66
Editorial: A year in review: discussions in molecular and structural endocrinology 65
NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness" 64
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer 64
Crosstalk between notch, HIF-1α and GPER in breast cancer EMT 63
Cancer stem cells (CSCs): Metabolic strategies for their identification and eradication 63
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 62
The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1α (HIF-1α) in breast cancer cells and cardiomyocytes 62
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets 61
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity 60
G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts 60
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 60
Editorial: Early diagnoses and treatments of uncommon breast cancers 60
The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells 59
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 59
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 58
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 58
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) 56
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 56
GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment 56
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 55
Estrogen Receptors and Chronic Venous Disease 55
Crucial role of phospholamban phosphorylation and s-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart 55
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State 52
Microenvironmental determinants of cancer progression during obesity: emerging evidence and novel perspectives 52
The cholesterol metabolite 25-Hydroxycholesterol activates estrogen receptor α-Mediated signaling in cancer cells and in cardiomyocytes 51
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 50
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 50
Protective role of GPER Agonist G-1 on cardiotoxicity induced by doxorubicin 49
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 47
Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells 46
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 45
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 45
GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells 44
Two novel GPER agonists induce gene expression changes and growth effects in cancer cells 44
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 44
Harnessing sample preparation for RNA-sequencing toward a reliable bioinformatics analysis 43
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 43
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy 43
SLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cells 42
Multifactorial regulation of GPER expression in cancer cells and cardiomyocytes 41
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 41
GPER mediates cardiotropic effects in Spontaneously Hypertensive Rat hearts 40
Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs) 39
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 38
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells 38
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling 37
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 35
Notch1 mediates preconditioning protection induced by GPER in normotensive and hypertensive female rat hearts 35
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 34
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response 34
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 33
GPER mediates activation of HIF1α/VEGF signaling by estrogens 32
A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 26
Translating the effect of dual lipid reduction with PCSK9 inhibitors on a mechanical vascular instrumental biomarker in familial hypercholesterolemia subjects 25
Pregnancy augments G protein estrogen receptor (GPER) induced vasodilation in rat uterine arteries via the nitric oxide - cGMP signaling pathway 25
The hidden threat: Microplastics and cancer biology 20
Assessment of N/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation 16
Stress-Inducible Transcription Factor NUPR1 Is Involved in the Inhibitory Effects Exerted by Statins on Insulin Action in ER-Positive Breast Cancer Cells 9
Totale 4.053
Categoria #
all - tutte 22.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 1 0 1 0 1 0 0
2022/20233 2 0 0 0 0 0 0 0 0 0 1 0
2023/2024441 0 1 1 0 1 1 2 63 75 76 156 65
2024/20251.292 85 72 92 35 183 103 84 58 205 170 127 78
2025/20262.314 165 439 379 267 61 96 252 207 218 161 40 29
Totale 4.053